Distribution · Africa · Announced 17 Sept 2026
Global Pharma → PrinceFarma
Distribution deal between Global Pharma (United Arab Emirates) and PrinceFarma (Angola), announced 17 Sept 2026. Value: Undisclosed.
Parties: Global Pharma Co LLC (United Arab Emirates) → PrinceFarma (Angola)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- Angola
- Therapeutic area
- Other
- Asset
- Globalpharma's product portfolio (therapeutic areas to be defined; core strengths = beta-lactam antibiotics + lifestyle-disease OSD/liquids)
- Announced
- 17 Sept 2026
Our analysis
Executive summary — what was actually signed, precisely
Not a distribution contract — an MoU to scope one. The parties will "evaluate regulatory, commercial and distribution pathways" and identify priority therapeutic areas — so no products, volumes or terms are committed yet. PrinceFarma provides Angolan registration and distribution reach; Globalpharma provides the portfolio. Signed by Dubai Investments Industries GM Mohammed Saeed Al Raqbani and PrinceFarma MD Aziz Rahemani.
The full analysis is free to read with a work email on this page.
Source: ZAWYA